Edgardo Concepcion, MD
Psychiatry · Lafayette, LANPI 1326123415
Payments from drug & device makers
Across 741 payments — averaging $19.68 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$3K
- Alkermes, Inc.$3K
- Otsuka America Pharmaceutical, Inc.$2K
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$2K
- Sunovion Pharmaceuticals Inc.$873
- Vanda Pharmaceuticals Inc.$788
- plus $3K from 23 others
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 168 | $2,879 |
| Alkermes, Inc. | 113 | $2,877 |
| Otsuka America Pharmaceutical, Inc. | 74 | $1,965 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 130 | $1,753 |
| Sunovion Pharmaceuticals Inc. | 95 | $873 |
| Vanda Pharmaceuticals Inc. | 30 | $788 |
| Johnson & Johnson | 33 | $644 |
| Teva Pharmaceuticals USA, Inc. | 16 | $518 |
| Axsome Therapeutics, Inc. | 11 | $469 |
| E.r. Squibb & Sons, L.L.C. | 10 | $258 |
| Neurocrine Biosciences, Inc. | 8 | $250 |
| Ironshore Pharmaceuticals Inc. | 7 | $243 |
| Janssen Scientific Affairs, LLC | 1 | $207 |
| Indivior Inc. | 13 | $197 |
| Lundbeck LLC | 9 | $165 |
| Tris Pharma Inc | 1 | $103 |
| Supernus Pharmaceuticals, Inc. | 4 | $61 |
| Eisai Inc. | 3 | $57 |
| Noven Therapeutics, LLC | 2 | $47 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $46 |
| Corium, LLC | 2 | $28 |
| Jazz Pharmaceuticals Inc. | 1 | $24 |
| Avanir Pharmaceuticals, Inc. | 1 | $23 |
| Adlon Therapeutics L.p. | 1 | $21 |
| Ardelyx, Inc. | 1 | $21 |
| Neos Therapeutics, LP | 1 | $19 |
| Noven Pharmaceuticals, Inc. | 1 | $18 |
| Rhodes Pharmaceuticals L.p. | 1 | $13 |
| Lilly USA, LLC | 1 | $13 |
How this compares
$14,580 in reported general payments places this provider in the 95th percentile of 474 psychiatry providers in Louisiana.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other psychiatry in Lafayette
- Bob WinstonLafayette$6K
- Catherine McDonaldLafayette$6K
- David DawesLafayette$5K
- Kashinath YadalamLake Charles$3.8M
- Guy BrannonShreveport$1.4M
- Patrick HayesLake Charles$853K
- Maria CruseThibodaux$522K
- Larry WarnerBaton Rouge$495K
- Gregory BrownShreveport$495K
- Arwen PodestaNew Orleans$466K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.